ASXC
Price
$0.24
Change
-$0.01 (-4.00%)
Updated
May 3, 6:59 PM EST
5 days until earnings call
EW
Price
$85.24
Change
+$0.19 (+0.22%)
Updated
May 3, 6:59 PM EST
82 days until earnings call
Ad is loading...

ASXC vs EW ᐉ Comparison: Which is Better to Invest?

Header iconASXC vs EW Comparison
Open Charts ASXC vs EWBanner chart's image
Asensus Surgical
Price$0.24
Change-$0.01 (-4.00%)
Volume$640.61K
CapitalizationN/A
Edwards Lifesciences
Price$85.24
Change+$0.19 (+0.22%)
Volume$630.04K
CapitalizationN/A
View a ticker or compare two or three
ASXC vs EW Comparison Chart

Loading...

ASXCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
EWDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ASXC vs. EW commentary
May 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASXC is a Hold and EW is a StrongSell.

COMPARISON
Comparison
May 05, 2024
Stock price -- (ASXC: $0.24 vs. EW: $85.25)
Brand notoriety: ASXC: Not notable vs. EW: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ASXC: 52% vs. EW: 67%
Market capitalization -- ASXC: $59.84M vs. EW: $57.52B
ASXC [@Medical Specialties] is valued at $59.84M. EW’s [@Medical Specialties] market capitalization is $57.52B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASXC’s FA Score shows that 0 FA rating(s) are green whileEW’s FA Score has 0 green FA rating(s).

  • ASXC’s FA Score: 0 green, 5 red.
  • EW’s FA Score: 0 green, 5 red.
According to our system of comparison, EW is a better buy in the long-term than ASXC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASXC’s TA Score shows that 3 TA indicator(s) are bullish while EW’s TA Score has 4 bullish TA indicator(s).

  • ASXC’s TA Score: 3 bullish, 5 bearish.
  • EW’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, EW is a better buy in the short-term than ASXC.

Price Growth

ASXC (@Medical Specialties) experienced а -3.21% price change this week, while EW (@Medical Specialties) price change was -1.37% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.22%. For the same industry, the average monthly price growth was -2.71%, and the average quarterly price growth was +13.71%.

Reported Earning Dates

ASXC is expected to report earnings on Aug 07, 2024.

EW is expected to report earnings on Jul 25, 2024.

Industries' Descriptions

@Medical Specialties (+2.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for ASXC with price predictions.
OPEN
A.I.dvisor published
a Summary for EW with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
EW($57.5B) has a higher market cap than ASXC($59.8M). EW YTD gains are higher at: 11.803 vs. ASXC (-24.428). EW has higher annual earnings (EBITDA): 1.76B vs. ASXC (-74.39M). EW has more cash in the bank: 1.64B vs. ASXC (21.1M). ASXC has less debt than EW: ASXC (5.68M) vs EW (695M). EW has higher revenues than ASXC: EW (6.01B) vs ASXC (8.58M).
ASXCEWASXC / EW
Capitalization59.8M57.5B0%
EBITDA-74.39M1.76B-4%
Gain YTD-24.42811.803-207%
P/E RatioN/A40.98-
Revenue8.58M6.01B0%
Total Cash21.1M1.64B1%
Total Debt5.68M695M1%
FUNDAMENTALS RATINGS
ASXC vs EW: Fundamental Ratings
ASXC
EW
OUTLOOK RATING
1..100
5453
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
10064
SMR RATING
1..100
9943
PRICE GROWTH RATING
1..100
6455
P/E GROWTH RATING
1..100
10054
SEASONALITY SCORE
1..100
7515

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ASXC's Valuation (37) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for EW (82) in the Medical Specialties industry. This means that ASXC’s stock grew somewhat faster than EW’s over the last 12 months.

EW's Profit vs Risk Rating (64) in the Medical Specialties industry is somewhat better than the same rating for ASXC (100) in the Miscellaneous Commercial Services industry. This means that EW’s stock grew somewhat faster than ASXC’s over the last 12 months.

EW's SMR Rating (43) in the Medical Specialties industry is somewhat better than the same rating for ASXC (99) in the Miscellaneous Commercial Services industry. This means that EW’s stock grew somewhat faster than ASXC’s over the last 12 months.

EW's Price Growth Rating (55) in the Medical Specialties industry is in the same range as ASXC (64) in the Miscellaneous Commercial Services industry. This means that EW’s stock grew similarly to ASXC’s over the last 12 months.

EW's P/E Growth Rating (54) in the Medical Specialties industry is somewhat better than the same rating for ASXC (100) in the Miscellaneous Commercial Services industry. This means that EW’s stock grew somewhat faster than ASXC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASXCEW
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
66%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 2 days ago
60%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
60%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
ASXCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
EWDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AQST3.520.24
+7.32%
Aquestive Therapeutics
ELV526.961.35
+0.26%
Elevance Health
GLP47.750.09
+0.19%
Global Partners LP
VTVT23.63-0.07
-0.29%
vTv Therapeutics
GIL33.10-0.43
-1.28%
Gildan Activewear

ASXC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASXC has been loosely correlated with RVTY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ASXC jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASXC
1D Price
Change %
ASXC100%
-1.63%
RVTY - ASXC
36%
Loosely correlated
-0.46%
EW - ASXC
30%
Poorly correlated
+0.22%
ITGR - ASXC
29%
Poorly correlated
+1.23%
BNGO - ASXC
29%
Poorly correlated
+0.07%
ALGN - ASXC
29%
Poorly correlated
+0.46%
More

EW and

Correlation & Price change

A.I.dvisor indicates that over the last year, EW has been loosely correlated with RVTY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if EW jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EW
1D Price
Change %
EW100%
+0.22%
RVTY - EW
53%
Loosely correlated
-0.46%
SYK - EW
45%
Loosely correlated
+0.56%
TFX - EW
45%
Loosely correlated
+2.15%
MDT - EW
45%
Loosely correlated
+0.95%
ISRG - EW
44%
Loosely correlated
+0.98%
More